Evidence map›Paper›PMID 40764568›Full record

ArticleBMC public health2025

Experiences of long-term benzodiazepine use and addiction amid changes in guidelines for the prescription of narcotic drugs: a qualitative study.

Cecilia Krüger, Mathilde Hedlund Lindberg, Sofia Burmester, Johan Franck, Jeanette Westman

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Neuroproteomic Profiling of the Anxiolytic Potential ofInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cecilia KrügerDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels allé 23, Huddinge, 141 52, Sweden. cecilia.kruger@ki.se.
Mathilde Hedlund LindbergDepartment of Medical Sciences, Clinical Pyschiatry, Uppsala University, Uppsala, 751 85, Sweden.
Sofia BurmesterDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels allé 23, Huddinge, 141 52, Sweden.
Johan FranckThe Stockholm Centre for Dependency Disorders, Stockholm Health Care Services, Region Stockholm, Friskvårdsvägen 4, Stockholm, 112 81, Sweden.
Jeanette WestmanDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels allé 23, Huddinge, 141 52, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAddiction to sedative, hypnotic, and anxiolytic drugs (collectively referred to as benzodiazepines), medications commonly used to treat anxiety and sleeping problems, has been described as a hidden epidemic. Growing concerns about addiction and other negative outcomes associated with use of these narcotics have resulted in their regulation and recommendations for more restrictive prescription. However, there are few studies on experiences of long-term benzodiazepine use from the user perspective, and even fewer focusing on people with addiction, who may be the most affected by changing regulations. The aim of this study was to explore experiences of people with long-term use and addiction to benzodiazepines during a time of major changes in guidelines for the prescription of narcotic drugs.

methodsThis qualitative study included nineteen individual interviews with adults (> 18 years) diagnosed with addiction to benzodiazepines who were undergoing treatment at an urban outpatient clinic in Sweden. The in-depth interviews were pseudonymized, transcribed verbatim, and analyzed using reflexive thematic analysis.

resultsTwo themes highlight the effect of changing prescription guidelines on long-term benzodiazepine users. The first theme, benzodiazepines were not always seen as problematic, but neither were the risks discussed, underscores the absence of psychiatric assessments and conversations about risks at the time of first prescription and highlights the need for clearer communication. The second theme, entangled in continued benzodiazepine use and increasing restrictions on prescribing, illustrates how addiction developed over time and describes how limited contact with prescribers facilitated long-term use, which often persisted until the participants were faced with deprescription.

conclusionsThis study describes the experiences of individuals with long-term use and addiction to benzodiazepines during a time of shifting attitudes towards prescribing. The results highlight areas for improvement in care for this vulnerable group of patients, including the need for proactive and regular communication about risks of addiction and additional support during deprescription.

Indexed as

BenzodiazepinesPractice Guidelines as TopicSubstance-Related DisordersAdultFemaleHumansHypnotics and SedativesInterviews as TopicMaleMiddle AgedQualitative ResearchSwedenBenzodiazepinesHypnotics and SedativesAddictionBenzodiazepinesDrug usePatient experiencesQualitativeSubstance-related disorders

Identifiers

PMID40764568
PMCPMC12326687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.